The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index; 5 of the 22 sources its claims cite were checked for support.
Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department
Open accessAbstract
Objective: We sought to estimate the period prevalence of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infection (SSTI) and evaluate risk factors for MRSA SSTI in an emergency department (ED) population. Methods: We carried out a cohort study with a nested case–control design. Patients presenting to our ED with a wound culture and a discharge diagnosis of SSTI between January 2003 and September 2004 were dichotomized as MRSA positive or negative. Fifty patients with MRSA SSTI matched by calendar time to 100 controls with MRSA-negative SSTI had risk factors assessed using multivariate conditional logistic regression. Results: Period prevalence of MRSA SSTI was 54.8% (95% confidence interval [CI] 50.2%–59.4%). The monthly period prevalence increased from 21% in January 2003 to 68% in September 2004 (p < 0.01). Risk factors for MRSA SSTI were injection drug use (IDU) (odds ratio [OR] 4.6, 95% CI 1.4–16.1), previous MRSA infection and colonization (OR 6.4, 95% CI 2.1–19.8), antibiotics in 8 weeks preceding index visit (OR 2.6, 95% CI 1.2–8.1), diabetes mellitus (OR 4.1, 95% CI 1.4–12.1), abscess (OR 5.6, 95% CI 1.8–17.1) and admission to hospital in previous 12 months (OR 2.6, 95% CI 1.1–11.2). Conclusion: The period prevalence of MRSA SSTI between January 2003 and September 2004 was 54.8% at our institution. There was a marked increase in the monthly period prevalence from the beginning to the end of the study. Risk factors are IDU, previous MRSA infection and colonization, prescriptions for antibiotics in previous 8 weeks and admission to hospital in the preceding 12 months. On the basis of local prevalence and risk factor patterns, emergency physicians should consider MRSA as a causative agent for SSTI.
Overview
CoChat Summary
TL;DR
In a Canadian inner-city emergency department, MRSA caused 54.8% of cultured skin and soft tissue infections between January 2003 and September 2004, with monthly prevalence rising from 21% to 68%. Independent risk factors included previous MRSA, injection drug use, abscess, diabetes, recent antibiotics, and recent hospital admission.
Key findings
- Period prevalence of MRSA SSTI was 54.8% (95% CI 50.2%–59.4%) among 447 infection-site cultures from 2,234 patients diagnosed with SSTI; monthly prevalence increased from 21% in January 2003 to 68% in September 2004 (p for trend < 0.001).
- In multivariate conditional logistic regression, significant risk factors were previous MRSA infection/colonization (OR 6.4, 95% CI 2.1–19.8), abscess (OR 5.6, 95% CI 1.8–17.1), injection drug use (OR 4.6, 95% CI 1.4–16.1), diabetes mellitus (OR 4.1, 95% CI 1.4–12.1), antibiotics in the prior 8 weeks (OR 2.6, 95% CI 1.2–8.1), and hospital admission/surgery in the previous 12 months (OR 2.6, 95% CI 1.1–11.2).
- Sex, age, anatomical area of infection, and long-term care residence were not associated with MRSA SSTI and were not retained in the final model.
- Among MRSA-negative cultures, 46% grew MSSA, 25% streptococcal species, 6% gram-negative organisms, and 18% grew no bacterial organisms.
Methods
- Cohort study with a nested case-control design in a tertiary care inner-city ED with approximately 65,000 patient visits per year; patients presenting January 2003–September 2004 with a wound culture and discharge diagnosis of SSTI were classified as MRSA-positive or MRSA-negative.
- Fifty MRSA SSTI cases were randomly selected and individually matched by calendar date of culture (±2 months) to 100 MRSA-negative controls; risk factors were assessed using multivariate conditional logistic regression.
- Data were abstracted from the New Emergency Resource Database, electronic order entry, printed medical/hospital records, and provincial PharmaNet data; the research assistant was blinded to case/control status, and 15 randomly selected records were audited for accuracy.
Limitations
- Stated: only 20% of patients with an SSTI discharge diagnosis had a wound swab performed, and culturing was at emergency physician discretion, so patients at higher MRSA risk may have been cultured more often, potentially overestimating prevalence.
- Stated: the case-control design is subject to selection and confounding biases; the inner-city demographic may limit external validity, and the study could not differentiate community-associated from hospital-associated MRSA.
- Evident from the text: the authors note the study was retrospective, and the prevalence estimate is based only on cultured patients, though they calculate that even if all uncultured SSTI patients were assumed MRSA-negative, period prevalence would still be 11% (245/2,234).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
5 Valid · 0 Not valid · 10 Not checked · 55 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although other Canadian data are lacking, our finding is consistent with data from a Los Angeles ED study 14 that reported that 44/96 (46%) of infection site cultures from SSTI grew MRSA.”
What the sources say
- Supportedcites [14] 14. Moran GJ, Amii RN, Abrahamian FM, et al. Methicillinresistant staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 2005;11:928-30. source
The Study reports MRSA in 44 of 96 patients (46%). It identifies the setting as a Los Angeles-area emergency department and says cultures were obtained from the infection sites of enrolled SSTI patients. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Intravenous drug use and HIV status were highly correlated.”
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The demographic of our inner-city patient population is reflected by the 20% of controls and 42% of cases who reported being injection drug users.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It is striking that the proportion of MRSA-positive infection site cultures from SSTIs increased from 22% to 68% during a 21-month period at our institution.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thirty-four percent of MRSA cases in this study had 1 or more of these clinical risk factors for hospital-associated MRSA.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
30 more claims
Create a free account to see all 70 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 28
- It may state two separate claims as one. 16
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it has been cultured from 54.8% of skin and soft tissue infections of patients seen at the emergency department of St. Paul’s Hospital (9).”
From Bedbugs as vectors for drug-resistant bacteria (2011) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“MRSA is also a substantial problem in the Downtown Eastside; it has been cultured from 54.8% of skin and soft tissue infections of patients seen at the emergency department of St. Paul’s Hospital (9).”
From Bedbugs as vectors for drug-resistant bacteria (2011) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Period prevalence of MRSA SSTI · p. 5
“from 21% of all cultures to 68% of all cultures at the end of the study period”
§ DISCUSSION · p. 6
“from 22% to 68% during the study period”
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042683 · Cited by 1,053
Frazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.10.011 · Cited by 494
Tacconelli, E., De Angelis, G., Cataldo, M. A., Pozzi, E., & Cauda, R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm416 · Cited by 435
Genestier, A.-L., Michallet, M.-C., Prévost, G., Bellot, G., Chalabreysse, L., Peyrol, S., Thivolet, F., Etienne, J., Lina, G., Vallette, F. M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22684 · Cited by 416
Groom, A. V. (2001) · JAMA · doi:10.1001/jama.286.10.1201 · Cited by 360
Eady, E. A., & Cove, J. H. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200304000-00007 · Cited by 329
Lindenmayer, J. M., Schoenfeld, S., O'Grady, R., & Carney, J. K. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.895 · Cited by 298
Methicillin-resistant Staphylococcus aureus in Community-acquired Skin Infections
Moran, G. J., Amii, R. N., Abrahamian, F. M., & Talan, D. A. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1106.040641 · Cited by 278
Research works printed but not linked: 3
- 2007, Commun Dis Intell, 31, 288
- 2008, J Antimicrob Chemother, 61, 26
- 2000, Centers for Disease Control and National Center for Infectious Diseases Focus, 9, 4
Cited by
Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections
Linz, M. S., Mattappallil, A., Finkel, D., & Parker, D. (2023) · Antibiotics · doi:10.3390/antibiotics12030557 · Cited by 293
“This includes a host of co-morbidities, such as cardiovascular disease, peripheral vascular disease, diabetes mellitus, renal disease, chronic wounds, immunosuppression, IV drug use, and presence of an abscess [26,27].”
BackgroundKurd, M. F., Ghanem, E. S., Steinbrecher, J., et al. (2010) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-010-1296-6 · Cited by 126
“residing in a long-term care facility or hospital admission in the preceding 12 months, intravenous drug use, recent antibiotic use, diabetes mellitus, HIV, and abscess formation [15, 21, 22].”
BackgroundTognetti, L., Martinelli, C. V., Berti, S., Hercogova, J. T., Lotti, T., Leoncini, F., & Moretti, S. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04416.x · Cited by 111
Leong, H. N., Kurup, A., Tan, M. Y., Kwa, A. L., Liau, K. H., & Wilcox, M. H. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s172366 · Cited by 109
“Factors contributing to the development of MRSA SSTIs are intravenous drug use, HIV seropositivity, MRSA colonization or previous infection, African-American race, indwelling devices, and previous antibiotics or hospitalizations.(11,28) The strains of CA-MRSA are genetically and Table 1 Skin and soft tissue infections…”
Loewen, K., Schreiber, Y., Kirlew, M., Bocking, N., & Kelly, L. (2017) · Europe PMC (PubMed Central) · Cited by 92
Metadata
- Authors
- Stenstrom, R., Grafstein, E., Romney, M., Fahimi, J., Harris, D., Hunte, G., Innes, G., & Christenson, J.
- Affiliations
- Providence Health Care (CA)
- University of British Columbia (CA)
- Corresponding author
- Stenstrom, Robert
- Venue
- CJEM
- Published
- 2009-09
- Volume
- 11
- Issue
- 05
- Pages
- 430-438
- ISSN
- 1481-8035 (ISSN-L)
- 1481-8043
- OpenAlex
- W2122890348
- Cited by
- 53
- References
- 21
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 1 · 2019: 2 · 2018: 5 · 2017: 3 · 2016: 5 · 2015: 4 · 2013: 2 · 2012: 5
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Canadian Journal of Emergency Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- methicillin-resistant Staphylococcus aureus, skin and soft tissue infections, period prevalence, risk factors, intravenous drug use, MRSA colonization, antibiotic use, diabetes mellitus, abscess, hospitalization, emergency department patients
- MeSH terms
- British Columbia, Emergency Service, Hospital, Female, Hospitals, Urban, Humans, Male, Middle Aged, Risk Factors, Staphylococcal Infections, Staphylococcal Skin Infections, Prevalence, Chi-Square Distribution, Logistic Models, Case-Control Studies, Soft Tissue Infections, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department. https://app.cochat.ai/papers/10.1017/s1481803500011623
- The paper
- Stenstrom, R., Grafstein, E., Romney, M., Fahimi, J., Harris, D., Hunte, G., Innes, G., & Christenson, J. (2009). Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department. CJEM. https://doi.org/10.1017/s1481803500011623
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.